Best published PK (Awosemo et al., 2021, rats): ~38% oral bioavailability, ~6 to 7 hr oral half-life
Most people notice an energy shift within the first day or two
Here are some AOD 9604 side effects you should know about: In clinical trials, AOD 9604 has shown fewer side effects compared to other human growth hormone treatments
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
Important limitations you should know For people with normal B12 levels, the evidence is far less compelling
Your doctor will decide whats best